Viatris Initiates Trial for Cenerimod in Active Lupus Nephritis
A clinical trial is underway to assess the efficacy and safety of cenerimod for treating active lupus nephritis in adults.
Asset / Drug
Drug and asset intelligence for Viatris with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.